ELVN:NASDAQ
Enliven Therapeutics Inc
$34.71
arrow_downward
-2.20%(-0.78) 1D
Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ELVN...
Open
$35.44
High
$36.07
Low
$33.68
Mkt. cap
2.11B
Avg. vol.
685.45K
Volume
0.00
52-wk high
$48.53
52-wk low
$14.78
EPS
-$1.66
Beta
0.29
Shares outstanding
60.90M
No. of employees
61
Open
$35.44
High
$36.07
Low
$33.68
Mkt. cap
2.11B
Avg. vol.
685.45K
Volume
0.00
52-wk high
$48.53
52-wk low
$14.78
EPS
-$1.66
Beta
0.29
Shares outstanding
60.90M
No. of employees
61
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to ELVN in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ELVN in the last 3 months.
Highest
Current $34.71
$80.00 (+130.48%)
Average
$59.57 (+71.62%)
Lowest
$45.00 (+29.65%)
News stories
From sources across the web
Yahoo Finance
·
13 hours ago
A Look At Enliven Therapeutics (ELVN) Valuation As ENABLE Trial Data Update Nears
About Enliven Therapeutics Inc
CEO-
Employees61
Founded2016
HeadquartersBoulder, Colorado, United States
SectorPharmaceutical industry
Websiteimaratx.com
AI content may include mistakes. Learn more